Tumgik
#DNA Testing Laboratory in India
greenarraylab · 1 year
Text
0 notes
astra-galaxie · 10 months
Text
Tumblr media
Victoria Holt
Biographical information
Full Name: Victoria Holt
Alias(es): Nerium Nightshade
Gender: Female
Sexuality: Lesbian
Status: Deceased
Age: 60 (season 1)
Birth: 1953
Race: Human
Cause of Death: Electrocution
Nationality: Dutch
Origin: Holland, Netherlands
Residence:
India (formerly)
Holland, Netherlands (formerly)
Profession(s): Scientist
Affiliation(s):
Switch Laboratories
SOMBRA
Profile
Height: 5'4" Age: 60 (season 1) Weight: 137lbs Eyes: blue Blood: A+
Hailing from the Netherlands, Victoria Holt was the owner of Switch Laboratories. She had strawberry-blonde hair, pale skin, and blue eyes. She wore a simple red dress, an orange lab coat, and a DNA pattern scarf.
Synopsis
Victoria was the victim of A Shock to the Team.
She used to own Switch Laboratories, a lab that, on the surface, was working to cure diseases. But behind the scenes, they were creating custom poisons to kill people. Victoria and Gustave were the only ones aware of SL's true intentions; the rest of the employees thought they were doing good work.
But unknown to Gustave, Victoria worked for SOMBRA, who also funded her operations. SOMBRA was using Victoria's poisons to "weed out the weak" but killing their enemies. Because Victoria's poisons were so unique, it would appear like people died of natural causes, such as a heart attack or stroke. She also sold her poisons privately on the black market, and no one traced these murders back to Victoria.
But Nathan eventually discovered Victoria's devious plans. He learned the truth while autopsying one of the volunteer test subjects. After realizing that Project Elysium was killing people on purpose instead of saving them, he contacted his grandfather, the Director of U.N.I.T at the time. With the agency's help, they destroyed the lab and research, arresting many of the employees.
But Victoria fled with SOMBRA's help and vowed revenge on Nathan for his betrayal. She couldn't believe after everything she did for him; he would stab her in the back. She gave him his sight, helped with his education, gave him a job at her lab, and that was how he repaid her?!
She stayed a free woman for many years as she evaded U.N.I.T. Victoria tried to recreate her work, but without the data, she couldn't do it. And then she realized that Nathan would be the key to helping her. He helped U.N.I.T. confiscate her work and was sure he would have remembered the formulas and know how to recreate them.
So, Victoria contacted Gustave, who was now out of prison, and the two tracked Nathan down to Grimsborough. They also found other old employees of SL, but no one wanted anything to do with them. But the two were persistent and tried to restart their work in a secret lab hidden underneath an abandoned iPear store Gustave owned.
Victoria even went as far as to threaten Nathan's son Avi. The coroner agreed to go with her to the lab so that she wouldn't hurt the boy, but once there, he attacked Victoria, knocking her out. He tried to destroy the work inside but found no files, so he fled before she woke up.
But Nathan knocking Victoria out would make it easier for Gustave to murder her. Gustave was angry when he saw that Victoria had failed to get Nathan back. He knew he could get the coroner to cooperate with the right incentives, and if she were going to be useless, he wouldn't risk her ruining his chances at a better life.
Gustave strapped Victoria to a chair and hooked up jumper cables to it and the shop's electric panel. With a flick of a switch, he turned on the shop's sign and electrocuted Victoria in the process. He left her burnt corpse inside and began formulating a plan to escape Grimsborough, taking Nathan with him.
Story Information
First appeared: A Shock to the Team
Trivia
The name of the case she was a victim in, A Shock to the Team, is a reference to the pilot episode (A Shock to the System) from the cartoon Static Shock
The SOMBRA connection was a change I made after I edited my first story, The Case of The Criminal, in 2021
She sold her custom poisons on the black market under the disguise of Nerium Nightshade
She wore a mask when making sales; the most common ones looked like skulls
Disclaimer: Character design was created using Rinmarugames Mega Anime Avatar Creator! I have only made minor edits to the design! Background courtesy of CriminalArtist5
Links to my stories:
The Case of the Criminal (Ao3/Wattpad) Killer Bay (Ao3/Wattpad) Where in the World are the Killers? (Ao3/Wattpad)
3 notes · View notes
biotechstudentlife · 1 year
Photo
Tumblr media
Carbohydrate MCQ 11 Link in bio 👆 for more mcqs recommendation #pcr #covid #coronavirus #pixelcarracer #rrna #dna #laboratory #corona #pixelart #laboratorio #dopepixels #biotechnology #microbiology #medicina #biology #lab #pcrtest #policie #sequence #test #pixelcar #salud #science #virus #biologyteacher #enfermagem #genetics #pixelracer #pcgaming #genes (at Delhi, India) https://www.instagram.com/p/CouKQEgvy5z/?igshid=NGJjMDIxMWI=
2 notes · View notes
omkarpatel · 2 months
Text
Surface Plasmon Resonance is Estimated to Witness High Growth Owing to Opportunity to Develop Biosensor Applications
Tumblr media
Surface Plasmon Resonance (SPR) is a powerful optical technique for characterizing biomolecular interactions. It enables the label-free detection and analysis of biomolecular interactions in real-time, providing important information about kinetics, affinity and concentration of interactions. SPR has wide applications in detecting or measuring proteins, dna, virus and biomarkers. It is commonly used to determine epitope mapping, antibody screening, protein complex formation, agglutination analysis, and receptor-ligand interactions. SPR applications have grown beyond basic bio-interaction analysis and SPR biosensors have emerged in medical diagnostics, food safety testing, and environmental monitoring. The global Surface Plasmon Resonance Market is estimated to be valued at US$ 976.1 Mn in 2023 and is expected to exhibit a CAGR of 6.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: The opportunity to develop biosensor applications of Surface Plasmon Resonance technology is driving the market growth. SPR biosensors have potential applications in detecting disease biomarkers in real time with high sensitivity. Research is ongoing to use SPR for developing portable biosensors to detect pathogens, toxins and proteins related to cancer, cardiac or infectious diseases directly from biological samples. SPR based biosensors could enable point-of-care testing without the need for specialized technicians or laboratory settings. This will increase accessibility of diagnostics. Development of cost-effective SPR biosensors has potential to disrupt the healthcare diagnostics market. Porter's Analysis Threat of new entrants: The threat of new entrants is moderate as surface plasmon resonance instruments require high upfront capital investments and expertise to operate. Research and development in this field is also costly. Bargaining power of buyers: The bargaining power of buyers is moderate to high as there are many established suppliers in the market providing similar products. Buyers can negotiate for better price and quality. Bargaining power of suppliers: The bargaining power of suppliers is moderate as they depends on few automated instrumentation and consumable parts suppliers. Supplier switching cost is moderate. Threat of new substitutes: Threat of new substitutes is low as SPR technique has well established itself in the market and no major substitute technology provides its advantages. Competitive rivalry: The competition in the market is high among major players to increase their revenue share. SWOT Analysis Strength: SPR offers direct, real-time detection of biomolecular interactions without labelling. It has high sensitivity and reproducibility. Weakness: High instrumentation and consumable costs. Require skilled personnel for operation and data analysis. Opportunity: Growing proteomics, metabolomics and biomarker research will boost demand. Increasing R&D investments in pharmaceutical industries offer opportunities. Threats: Slow adoption in developing countries due to budget constraints. Competition from emerging label-free detection technologies. Key Takeaways The global surface plasmon resonance market is expected to witness high growth supported by ongoing protein-protein interaction and clinical biomarker studies. North America dominates the market currently owing to extensive R&D activities in the region. The market in Asia Pacific is expected to witness fastest growth over the forecast period with increasing government investments in life science research in countries like China and India. Key players operating in the surface plasmon resonance market includes Bio-Rad Laboratories, Inc., Carterra Inc., AMETEK, Inc., Bristol Myers Squibb, Horiba, Ltd., Bruker, and Biosensing Instrument Inc. Major players are focusing on new product launches with advanced features and geographical expansion strategies to gain higher revenue shares in the global market.
0 notes
Text
Global Molecular Diagnostics Market ,Research and Analysis by Expert: Market Size, Cost Structures and Industry Analysis 2020-2030
Overview
Global Molecular Diagnostics Market was valued at USD 8.74 billion in 2019 which is expected to reach at USD 13.58 billion by 2030 at a CAGR 8.5%. Qualiket Research provide in depth analysis of global molecular diagnostics market with latest trends, and opportunities.
Key Players:
Major Key players are listed in global molecular diagnostics market report including Abbott Laboratories, Qiagen, Illumina, Hologic, Grifols, Diasorin, Danaher Corporation, Biomérieux, Becton, Dickinson and Company,and Agilent Technologies
 Request A Free Sample: https://qualiketresearch.com/request-sample/Molecular-Diagnostics-Market/request-sample
Market segmentation
The report have segmented global molecular diagnostics market according to the product and services such as Reagents & Kits, Instruments, and Software & Service, by technology such as Polymerase Chain Reaction (PCR), DNA Sequencing and NGS, Isothermal Nucleic Acid Amplification Technology, DNA Microarrays, In Situ Hybridization, and Others, by application such as Infectious Diseases, Oncology, Genetic Tests, and Others. Further, market is segmented into end user such as Hospital and Academics Laboratories, Reference Laboratories, and Others.
Read More Here: https://qualiketresearch.com/reports-details/Molecular-Diagnostics-Market
Key Features
Reagents and kits held the largest market share in 2019 and which is also fastest growing product segment due to its high adoption in research and clinical settings.
Infectious diseases is also largest revenue generating factor as molecular diagnostics provide clinicians with better substitutes to diagnose various infectious pathogens, virus, and bacteria with accurate results.
Qualiket Research report provide in depth analysis with latest market trends and key developments.
About Us:
QualiKet Research is a leading Market Research and Competitive Intelligence partner helping leaders across the world to develop robust strategy and stay ahead for evolution by providing actionable insights about ever changing market scenario, competition and customers.
QualiKet Research is dedicated to enhancing the ability of faster decision making by providing timely and scalable intelligence.
QualiKet Research strive hard to simplify strategic decisions enabling you to make right choice. We use different intelligence tools to come up with evidence that showcases the threats and opportunities which helps our clients outperform their competition. Our experts provide deep insights which is not available publicly that enables you to take bold steps.
Contact Us:
     6060 N Central Expy #500 TX 75204, U.S.A
     +1 214 660 5449
     1201, City Avenue, Shankar Kalat Nagar,
     Wakad, Pune 411057, Maharashtra, India
     +91 9284752585
     Sharjah Media City , Al Messaned, Sharjah, UAE.
     +971 56 846 4312        
0 notes
infinitiresearch · 3 months
Text
Bacterial Disease Diagnostics Market| Analysis, Growth and Forecast, 2023 – 2027
Originally published on Technavio: Bacterial Disease Diagnostics Market by Product, End-user, and Geography - Forecast and Analysis 2023-2027
The Bacterial Disease Diagnostics Market is poised for substantial growth from 2023 to 2027, driven by factors such as the increasing prevalence of bacterial infections, advancements in diagnostic technologies, and a growing emphasis on early and accurate disease detection. This market's dynamics will be shaped by various factors, including different diagnostic products, end-users, and geographical trends.
In terms of diagnostic products, the Bacterial Disease Diagnostics Market encompasses a range of tools and technologies for identifying bacterial infections. These products include molecular diagnostics, immunoassays, clinical microbiology instruments, and point-of-care testing devices. Molecular diagnostics, including Polymerase Chain Reaction (PCR) and nucleic acid amplification tests, enable the specific detection of bacterial DNA or RNA, providing high sensitivity and accuracy. Immunoassays, such as enzyme-linked immunosorbent assays (ELISA), detect bacterial antigens or antibodies, contributing to rapid and cost-effective diagnostics.
End-users in the Bacterial Disease Diagnostics Market primarily include hospitals and clinics, diagnostic laboratories, and research institutions. Hospitals and clinics play a crucial role in the frontline diagnosis and treatment of bacterial infections, relying on various diagnostic tools to guide patient management. Diagnostic laboratories, equipped with advanced technologies and trained personnel, contribute to comprehensive bacterial disease diagnostics. Research institutions drive innovation in diagnostic technologies, paving the way for the development of new and improved bacterial disease diagnostic methods.
Geographically, the market is expected to exhibit diverse trends. North America, Europe, and Asia-Pacific are anticipated to be major contributors to market growth. North America, with its well-established healthcare infrastructure and significant investments in research and development, is a key region for bacterial disease diagnostics. Europe, characterized by advanced healthcare systems and stringent regulatory standards, fosters the adoption of innovative diagnostic solutions. Asia-Pacific, including countries like China and India, witnesses a rising burden of bacterial diseases, creating opportunities for market expansion.
The forecast period is marked by ongoing advancements in bacterial disease diagnostic technologies, with a focus on improving speed, accuracy, and accessibility. Innovations include the development of rapid point-of-care testing devices for timely diagnostics, integration of artificial intelligence for data analysis, and the exploration of novel biomarkers for enhanced specificity. Additionally, the market is influenced by the growing trend towards multiplexed diagnostics, allowing simultaneous detection of multiple bacterial pathogens in a single test.
To Learn deeper into this report , View Sample PDF
Challenges in the Bacterial Disease Diagnostics Market include the need for standardization of diagnostic procedures, addressing the emergence of antibiotic-resistant bacteria, and ensuring accessibility to diagnostic tools in resource-limited settings. However, the market's growth prospects remain positive as the importance of early and accurate bacterial disease diagnosis gains prominence in global healthcare practices. The industry's evolution is characterized by a continuous quest for improved diagnostic accuracy, accessibility, and efficiency in addressing the complex challenges posed by bacterial infections.
For more information please contact.
0 notes
market-insider · 4 months
Text
Forensic Genomics Market Dynamics: Forensic Solutions in the Market
The global forensic genomics market size is expected to reach USD 1.36 billion by 2030, registering a CAGR of 14.25% in the forecast period, according to a new report by Grand View Research, Inc. This is owing to a significant increase in violent crimes, globally. Murder, intentional homicide, robbery, etc. are the key factors driving the growth of the industry. The Federal Bureau of Investigation predicted that there will be 1.31 million violent crimes in 2021. Homicides accounted for approximately 40.00% since before the pandemic, according to the FBI’s estimated homicide data. Forensic DNA profiling allows the identification of individuals of those who are already known to the investigating authorities.
Tumblr media
Forensic Genomics Market Report Highlights
The growth of the overall market is attributed to the increasing crime rates along with the introduction of advanced technology for forensic testing
Key players are focusing on several strategic alliances, which, in turn, is driving the global industry
For instance, in August 2022, Thermo Fisher Scientific entered into collaboration with National Forensic Sciences University (NFSU) to establish the center of excellence for DNA forensics in India
The facility is equipped with advanced technologies, which would help researchers make evidence-based decisions
In August 2022, Verogen, Inc. formed a partnership agreement with Gene by Gene to accelerate Forensic Investigative Genetic Genealogy (FIGG) Adoption
The partnership would provide affordable whole genome sequencing services for complex samples and standardize bioinformatic techniques for FIGG analysis
For More Details or Sample Copy please visit link @: Forensic Genomics Market Report
New genetic markers have been produced as a result of recent research and they have the potential to address some significant shortcomings in DNA profiling techniques. In addition, several developments allow new kinds of relevant information to be obtained from biological samples. These include new molecular techniques for locating individuals that investigators were previously unaware of, and novel molecular approaches to support connections between criminal acts and sample donors. Such advancements in genomics, genetics and molecular biology are expected to enhance human forensic casework in the coming years. Advancements in technology have helped scientists create DNA fingerprints with smaller samples of DNA, therefore a suspect can be identified from a small amount of blood sample.
Next-generation Sequencing (NGS) offers results quickly and at a lower cost than other conventional techniques. Accordingly, to improve DNA testing accuracy, the number of regions used in STR analysis increased from 13 to 20 in 2017. In February 2022, researchers from the University of Washington along with the U.S. Department of Homeland Security used DNA testing of ivory shipments confiscated by law enforcement to identify the global criminal groups involved in ivory smuggling out of Africa. The kits & consumables product segment captured the highest revenue share in 2021 due to the high public & private investments in the development of DNA forensics.
The consumables include centrifuge tubes, cotton swabs, and filter baskets among others. The capillary electrophoresis method segment dominated the industry in 2021. Capillary electrophoresis is a fully automated technique used for detecting and separating Short Tandem Repeat (STR) alleles in genomic laboratories. Criminal testing was the largest application segment in 2021 owing to the increasing use of molecular testing technology for criminal investigation. North America dominated the global industry in 2021 due to various technological developments in the forensic sciences and growing investigation consent for forensic processes, such as biometric analysis methods and DNA profiling.
0 notes
cmr-insights · 6 months
Text
Molecular Diagnostics Market Statistics and Global Analysis Report 2030
The Global Molecular Diagnostics Market was valued at US$ 15,843.6 Million in 2022 and is anticipated to reach US$ 36,766.9 Million by the end of 2030 with a CAGR of 11.1% from 2023 to 2030.
Make The Smart Decision. Download A Free Sample Of Our Report @ https://cognizancemarketresearch.com/request/molecular-diagnostics-market/
Businesses are increasingly conducting high-throughput molecular-level testing for infectious diseases. Companies are now offering molecular diagnostic tests that can identify various pathogens with a single patient sample.
The market’s growth is driven by large-scale bacterial and viral epidemics worldwide, the need for point-of-care diagnostics, advancements in pharmacogenomics, and rapidly evolving technology. According to the India TB Report 2022, the number of new and relapsed TB cases registered in India in 2022 was 1,933,381, compared to 1,628,161 in 2023. This suggests that increasing patient numbers and prevalence will drive demand for molecular diagnostics, boosting the market.
Due to the automation of the research process, molecular diagnostic systems are in high demand. These systems automate DNA extraction, amplification, and data analysis, resulting in improved productivity, accurate data, and faster results, all of which support the industry’s growth.
Molecular Diagnostics Market Amid COVID-19 Pandemic
Covid-19 has had a favorable effect on the global market for molecular diagnostics. The core of the COVID-19 reaction during the coronavirus disease pandemic is diagnostic. It helps with the containment efforts made to lessen the outbreak. Also, the number of businesses expanding their regional reach as a result of COVID-19 IVD test approval is anticipated to support market expansion.
Globally, the disturbance in the distribution networks around the globe has a significant impact on the seamless supply chains that guarantee higher quality, safety, and new techniques for transmission across the healthcare industry. With the quick development of diagnostics, expedited regulatory clearances, and increased dissemination in multiple locations to help slow the virus’ spread, COVID-19 has shone a spotlight on the global molecular diagnostics sector.
Due primarily to rising demand for polymerase chain reaction (PCR) tests, serology-based rapid-test products, next-generation sequencing (NGS), and a substantial increase in the target patient population, the demand for diagnostic products as a result of COVID-19 is anticipated to expand. By increasing the COVID-19 PCR catalog on the Cobas 5800 System in February 2022, for instance, Roche continued to give more individuals access to precise, quick, and efficient treatments in the battle against COVID-19. Because of this, more COVID-19 molecular diagnostic tests may be used, which would fuel the post-pandemic market’s expansion.
Increasing Prevalence of contagious disease, rapid technological advancement, growing R & D investment to Boost in Molecular Diagnostics Market
Molecular diagnostics is the method of identifying diseases by examining molecules such as proteins, DNA, and RNA in a tissue or liquid form. It is a group of techniques that apply molecular science to laboratory trials to dissect natural markers in the genome and proteome, as well as how cells express their genetics as proteins. In medicine, the technique is used to assess and track sickness, identify risks, and determine which therapies will work best for specific individuals. Agricultural biosecurity also includes crop and animal infection monitoring, risk assessment, and the selection of appropriate isolation measures. The most effective method for locating and describing a microbe is thought to be molecular diagnostics.
The rising prevalence of infectious disorders is the main factor propelling the growth of the global molecular diagnostics market. The main causes of morbidity and mortality in catastrophes, according to the WHO, are acute respiratory infections, measles, diarrheal diseases, and vector-borne diseases. The effects of seasonal influenza epidemics in impoverished countries are unknown, however, research has shown that 99% of children under the age of 5 who have lower respiratory tract illnesses connected to influenza die in these countries.
Rapid technical improvements are also accelerating the market’s expansion. For instance, molecular diagnostics is crucial in the diagnosis of infectious diseases because it provides quick and effective results. It functions with accuracy, economy, and portability. Moreover, advances in molecular diagnostics have helped in disease identification and are particularly useful when dealing with challenging differential diagnoses. Many organizations are enhancing their items by utilizing new strategies to obtain precise results that are also anticipated to support the market’s expansion. For the examination of malignancies, companies like QIAGEN and Sigma Aldrich Corporation are developing novel techniques like Transcription-Mediated Amplification & Loop-Mediated Isothermal Amplification (LAMP).
Yet, rising diagnostic costs and a lack of uniform and clear regulatory frameworks could restrain industry expansion. Despite this, increasing R&D spending may present more chances for the molecular diagnostics industry to expand.
North America to spearhead the Molecular Diagnostics market
The molecular diagnostics market is poised to lead the global market’s development in North America, driven by several key factors. Firstly, rising consumer awareness and an increase in disease occurrence contribute to the region’s growth. Additionally, technological advancements and a robust healthcare system in North America further facilitate the accessibility and availability of modern technologies such as molecular diagnostics.
Collaboration and association between research hospitals and academic institutions in the region play a pivotal role in driving market expansion. These organizations actively engage in discussions to enhance the molecular diagnosis process. Notably, the United States dominates this market, holding the largest income share due to its substantial existing market and advanced adoption of molecular diagnostics.
Moreover, the increasing incidence of contagious diseases in North America has prompted both public and private institutions to make significant investments in healthcare infrastructure and research and development to address the growing patient population.
Furthermore, the regulatory environment in North America is becoming more favorable, simplifying the launch of new drugs as regulatory agencies establish clearer policies and procedures for their approval.
Lastly, the region’s growing geriatric population, coupled with an emphasis on advanced technologies by leading players, contributes to the continuous development of the molecular diagnostics market in North America
Make The Smart Decision. Download A Free Sample Of Our Report @ https://cognizancemarketresearch.com/request/molecular-diagnostics-market/
Numerous key players in the global molecular diagnostics market, such as BD, bioMérieux SA, Bio-Rad Laboratories, Inc., Abbott, Agilent Technologies, Inc., Danaher, Hologic Inc. (Gen Probe), Illumina, Inc., Johnson & Johnson Services, Inc., Grifols, S.A., QIAGEN, F. Hoffmann-La Roche, Ltd., Siemens Healthineers AG, and Sysmex Corporation, are actively employing a range of strategies to enhance their market presence and revenue generation.
0 notes
delvenservices · 7 months
Text
Next Generation Sequencing (NGS) Market Growth Opportunities & Key Players
Next Generation Sequencing (NGS) Market, by Product (Consumables, Platforms, Services and Nerve Blockers), Application (Diagnostics, Biomarkers and Cancer, Reproductive Health, Personalized Medicine, Agriculture and Animal Research, and Other Applications), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real Time Sequencing, and Other Technologies), and End User (Academic and Research Centers, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, and Other End Users) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).
Market Overview
The global Next Generation Sequencing (NGS) market size was estimated at USD 11.59 billion in 2023 and is projected to reach USD 29.84 billion in 2030 at a CAGR of 14.47% during the forecast period 2023-2030.
Next-generation sequencing (NGS) is a massively parallel sequencing method that offers scalability, high throughput, and high speed for genome-wide sequencing of nucleotides. Because it involves the preparation of material for the subsequent sequencing reaction, DNA presequencing is one of the most important processes in a common sequencing protocol. Globally, NGS is increasingly integrated into clinical laboratory analysis, testing and disease diagnosis in the healthcare industry. In pharmacogenomics, next-generation sequencing (NGS) is often used to accelerate the drug discovery process.
Tumblr media
The growth of the global next-generation sequencing market is primarily driven by the growth of genome mapping programs; proliferation of next-generation sequencing applications; rising health care costs; and technological advances in sequencing platforms. For example, in 2019, Thermo Fisher Scientific, a world leader in scientific services, launched a new generation platform, the Ion Torrent Genexus System, which provides sample for one-day reporting. Additionally, Agilent Technologies, Inc., an American analytical development and manufacturing company, brought in 2019, we launched the Magnis NGS Prep System, a next-generation sequencing library preparation system designed to perform complex sequencing analyzes at the push of a button. Fetal genetic makeup and configuration can be detected with NGS-oriented tests such as non-invasive prenatal testing (NIPT) and pre-implantation genetic testing (PGT). R&D-related NGS has risen to new heights thanks to investments in NGS technologies worldwide. Growing demand for genome mapping software and increasing use of NGS is fueling market growth
During the COVID-19 pandemic, governments around the world partnered with the private sector to bring NGS technology to market as a potential diagnostic tool. The NGS diagnostic technique was able to determine the genetic sequence of the virus and helped researchers figure out how mutations occur. Next-generation sequencing (NGS) has been used to study COVID-19, making it much easier to trace the origin of SARS-CoV-2.
To Understand Business Strategies, Request for a Sample Report at: https://www.delvens.com/get-free-sample/next-generation-sequencing-ngs-market-trends-forecast-till-2030
Delvens Industry Expert's Standpoint
The pandemic had a considerable impact on businesses globally, with nations like India and China bearing the brunt of the virus's outbreak Declining sequencing costs have increased the use of NGS in disease diagnosis. Various testing kits and testing services are emerging for the non-invasive prenatal testing, cancer diagnosis, genetic testing and more, leading the global market. In addition, active support from the government through product approval and improvement of reimbursements for such diagnostic tests is expected to provide new opportunities for market growth. Additionally, increasing prevalence of chronic diseases, increase in research and initiation of high-budget genomics projects are expected to boost market growth during the forecast period. These factors have led to the expansion of the market and increased demand for Next Generation Sequencing (NGS) solutions.
Key Findings
The application segment is further fragmented into diagnostics, biomarkers & cancer, reproductive health, personalized medicine, agriculture & animal research, and other applications. The biomarker and cancer segment is expected to account for a larger market size during the forecast period due to increase in prevalence of cancer and advancement in technology in next generation sequencing. However, the personalized medicine segment is expected to witness considerable next generation sequencing market growth during the forecast period, due to surge in demand for drug treatment, advancement in R&D in healthcare sector, and rise in awareness for NGS testing in pharmaceutical and biotechnological industry.
The product type segment is further bifurcated into Consumables, Platforms, Services and Nerve Blockers. The consumables segment is the largest market during the forecast period owing to development of technology in molecular genetics and surge in demand for novel pre-sequencing products and kits that execute DNA fragmentation, target enrichment, size selection, and others. However, the services segment is expected to witness considerable next generation sequencing market growth during the forecast period, due to advancement in technology based on SMRT sequencing, and increase in application of cloud computing for NGS data storage.  
The end user segment is further bifurcated into Academic and Research Centers, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, and Other End Users. Academic & clinical research to account for a larger market size during the forecast period due to increase in application-based usage in these institutes and rise in oncology research. However, the pharmaceutical & biotechnology companies’ segment is expected to witness considerable market growth during the forecast period, due to increase in prevalence of chronic disease, and advancement in R&D in the next generation sequencing market for therapeutics, oncology, and genomics research.  
The market is also divided into various regions such as North America, Europe, Asia-Pacific, South America, and Middle East and Africa. North America is estimated to account for the largest market share during the forecast period. In North America, increasing number of genomics research projects, rising demand for new NGS platforms and growing use of NGS consumables are various factors projected to drive the growth.
To Grow Your Business Revenue, Make an Inquiry Before Buying at: https://www.delvens.com/Inquire-before-buying/next-generation-sequencing-ngs-market-trends-forecast-till-2030
Regional Analysis
North America to Dominate the Market
North America is estimated to account for the largest market share during the forecast period. In North America, increasing number of genomics research projects, rising demand for new NGS platforms and growing use of NGS consumables are various factors projected to drive the growth.
Competitive Landscape
10X Genomics
Agilent Technologies
BGI Group
Bio-Rad Laboratories Inc.
Brooks Automation Inc.
CD Genomics
DNASTAR Inc.
Eurofins Scientific
F. Hoffmann-La Roche Ltd.
Illumina Inc.
Macrogen Inc.
New England Biolabs
Novogene Corporation Inc.
Oxford Nanopore Technologies
Pacific Biosciences of California Inc.
PerkinElmer Inc.
Precigen Inc., (Intrexon Bioinformatics Germany GmbH)
Promega Corporation
Psomagen
Qiagen
Takara Bio
Tecan Trading Group
Thermo Fisher Scientific Inc.
Zymo Research
Recent Developments
In January, 2023, QIAGEN announced a strategic partnership with California-based population genomics leader Helix to advance next-generation sequencing companion diagnostics in hereditary diseases.  
In March, 2023, The company SOPHiA GENETICS announced a new partnership with Qiagen that will pair QIAseq reagent technology with the DDM platform to enhance tumor analysis through next-generation sequencing (NGS).
Direct Purchase of Research Report at: https://www.delvens.com/checkout/next-generation-sequencing-ngs-market-trends-forecast-till-2030
Reasons to Acquire
Increase your understanding of the market for identifying the most suitable strategies and decisions based on sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors.  
Gain authentic and granular data access for the Next Generation Sequencing (NGS) Market to understand the trends and the factors involved in changing market situations.  
Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future.  
In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns.
Report Scope
The Next Generation Sequencing (NGS) Market is segmented into various segments such as product, application, technology, end-user and region:
Based on Product
Consumables  
Sample Preparation Consumables  
DNA Fragmentation, End Repair, A-Tailing and Size Selection
Library Preparation & Target Enrichment
Quality Control
Other Consumables  
Platforms
HiSeq
MiSeq
Ion Torrent
Solid
Pacbio Rs II and Sequel System
Other Sequencing Platforms
Services  
Sequencing Services  
RNA Sequencing
Whole Exome Sequencing
Whole Genome Sequencing
Targeted Sequencing
Chip Sequencing
De Novo Sequencing
Methyl Sequencing
Data Management Services  
NGS Data Analysis Services
NGS Data Analysis Software & Workbenches
NGS Storage, Management and Cloud Computing Solutions
Based on Application
Diagnostics
Biomarkers and Cancer
Reproductive Health
Personalized Medicine
Agriculture and Animal Research
Other Applications
Based on the Technology
Sequencing by Synthesis
Ion Semiconductor Sequencing
Sequencing by Ligation
Pyrosequencing
Single Molecule Real Time Sequencing
Other Technologies
Based on End User
Academic and Research Centers
Pharmaceutical and Biotechnology Companies
Hospitals and Clinics
Other End Users
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact Us:
UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-8638-5055
0 notes
shradhacmi · 7 months
Text
Global Leukemia Screening Market Is Estimated To Witness High Growth Owing To Technological Advancements
The global Leukemia Screening Market is estimated to be valued at US$17.04 billion in 2023 and is expected to exhibit a CAGR of 6.4% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Leukemia screening is a vital diagnostic tool used for the early detection and monitoring of leukemia, a type of blood cancer. The market for leukemia screening is driven by the increasing prevalence of leukemia worldwide. The advantages of leukemia screening include early detection, accurate diagnosis, and better treatment outcomes. The need for these products is crucial as they help in identifying the disease at an early stage, allowing for timely intervention and improved chances of survival. Market Key Trends: One key trend in the leukemia screening market is the advent of technological advancements in screening techniques. The introduction of innovative technologies such as flow cytometry, polymerase chain reaction (PCR), and next-generation sequencing (NGS) has revolutionized the screening process. These advanced techniques offer higher sensitivity, specificity, and accuracy in detecting leukemia cells, leading to more accurate diagnosis and personalized treatment plans. For example, companies like Illumina and Thermo Fisher Scientific Inc. have developed NGS platforms that enable high-throughput sequencing of genomic DNA, providing detailed insights into the genetic alterations associated with leukemia. PEST Analysis: Political: Government initiatives and policies aimed at improving cancer screening programs can positively impact the leukemia screening market. Economic: Increasing healthcare expenditure and rising awareness among individuals about the importance of cancer screening contribute to the market's growth. Social: The growing prevalence of leukemia, especially among the aging population, underscores the need for efficient screening methods. Technological: Technological advancements in molecular diagnostics and genetic testing have significantly enhanced the accuracy and efficiency of leukemia screening. Key Takeaways: 1 - Market size related content: The global leukemia screening market is expected to witness high growth, exhibiting a CAGR of 6.4% over the forecast period, due to increasing awareness about early cancer detection and advancements in screening technologies. For example, the development of liquid biopsy techniques has revolutionized the screening process, allowing for non-invasive detection of Leukemia Screening Market in circulating blood. 2 - Regional analysis related content: North America is expected to dominate the leukemia screening market due to the presence of well-established healthcare infrastructure and increasing investments in cancer research. Asia Pacific is projected to be the fastest-growing region, driven by a rising geriatric population and increased healthcare spending in countries like China and India. 3 - Key players related content: Key players operating in the global leukemia screening market include F. Hoffmann-La Roche Ltd, Abbott Laboratories, Thermo Fisher Scientific Inc., Sysmex Corporation, Bio-Rad Laboratories, Inc., Illumina, Inc., QIAGEN N.V., Grifols, S.A., Siemens Healthineers AG, Agilent Technologies, Inc., Ortho Clinical Diagnostics, Biocept, Inc., Adaptive Biotechnologies Corporation, Invivoscribe, Inc., and ArcherDX, Inc. These companies focus on product development, collaborations, and mergers to strengthen their market position and expand their product offerings. In conclusion, the global leukemia screening market is experiencing significant growth due to technological advancements in screening techniques. The market's future looks promising, driven by the increasing prevalence of leukemia and the need for early detection to improve patient outcomes. Collaborations among key players and government initiatives to improve cancer screening programs further contribute to the market's expansion.
Tumblr media
0 notes
researchnews34 · 23 days
Text
Cervical Cancer Diagnostics Market Regional Predictions and Promising Growth Opportunities for 2023-2032
Cervical Cancer Diagnostics Market size is predicted to experience tremendous growth in the near future. Our research indicates that the market was crossed over USD 7.5 Billion in 2022 and is projected to record more than 5.6% growth rate from 2023 - 2032, reaching a valuation of approximately USD 11.8 Billion by the end of the forecast period.
The COVID-19 pandemic has had a tremendous impact on the world, causing immense human suffering, economic damage, and significant changes to the health, social, and environmental sectors. According to WHO, as of December 31, 2020, over 82 million people have been infected and 1.8 million have died from the virus. Supply chain management has struggled with the sudden increase in demand for certain products and the restrictions on travel and production that have been in place since the pandemic began. Companies are trying to adapt to the new reality, and changes that will persist after the pandemic is over are likely to emerge.
Download Free Sample Report @ https://www.marketvalueinsights.com/request-sample/554
Furthermore, the resilience challenge has been addressed in distinctly different ways by various industries. Healthcare providers stand out as resilience leaders, as 60% of healthcare respondents have regionalized their supply chains and 33% have relocated production closer to end markets.
Market Value Insights conducted a comprehensive analysis of the Cervical Cancer Diagnostics Market, utilizing a 360-degree approach that combines both primary and secondary research methods. This approach allowed us to gain a deep understanding of the current market conditions, including the supply-demand balance, pricing trends, customer preferences, and other important factors.
Our primary research involved collecting insights from industry experts and opinion leaders from around the world, allowing us to validate our findings and gain a broader perspective of the market. To ensure the accuracy and reliability of our data, we employed various market estimation and data validation techniques and developed a proprietary model to forecast market growth until 2032. By using these research methods, we provide our clients with a comprehensive understanding of the Cervical Cancer Diagnostics Market, allowing them to make informed business decisions and stay ahead of the competition.
Browse More @ https://www.marketvalueinsights.com/industry-reports/cervical-cancer-diagnostics-market/554
The North America region is expected to account for XX% of the global Cervical Cancer Diagnostics Market by 2032, due to the presence of major players in the region and the adoption of advanced technologies. The United States, which is the most technologically advanced and industrially developed country in the region, accounts for more than half of the North America market.
The Asia Pacific Cervical Cancer Diagnostics Market is projected to achieve a CAGR of XX% during the forecast period, driven by favorable government regulations and increasing industrialization in the region. The growth of economies such as China and India is expected to contribute to the growth of the market over the forecast period.
Top players in the Cervical Cancer Diagnostics Market are
F. Hoffmann-La Roche Ltd
Fujirebio Diagnostics, Inc.
Hologic, Inc.
QIAGEN
Seegene Inc
Abbott Laboratories
Arbor Vita Corporation
Becton, Dickinson and Company (BD)
Danaher Corporation
Thermo Fisher Scientific Inc.
In-depth analysis of Cervical Cancer Diagnostics Market for the below segments:
By Age Group (20-40 years, Above 40 years),
By Diagnostic Methods (Pap smear tests, HPV DNA tests, Colposcopy, Biopsy and endocervical curettage),
By End-use (Hospitals, Diagnostic laboratories, Diagnostic imaging centers, Cancer research institutes),
By Region (North America, Europe, Asia Pacific, Middle East and Africa, Latin America)
Download Free Sample Report @ https://www.marketvalueinsights.com/request-sample/554   
Related News –
Tumblr media
0 notes
nandinipatil · 9 months
Text
DNA Diagnostic Market
Global DNA Diagnostic Market value
Scope of Global DNA Diagnostic Market:
The latest business intelligence report on the DNA Diagnostic Market offers a comprehensive overview of the pivotal aspects pertaining to this industry vertical. It incorporates an accurate assessment of historical records, projections, growth drivers, opportunities, challenges, and restraints, among others.
This research literature fragments the industry in terms of (segments). It individually assesses each segment based on its scope and provides valuable insights on its top revenue prospects. By using proven research methodologies, this document further includes granular insights into the geographical landscape while providing a 360-degree outlook of the growth trajectory of the highlighted regions.
The study on DNA Diagnostic Market further characterizes the competitive terrain by incorporating crucial data about the top industry players. It comprises of the detailed portfolio of each of the mentioned companies while deeply scrutinizing the major strategies adopted by them to enhance their global footprint. The crucial components such as product pricing, partnerships, mergers & acquisitions, collaborations, and major developments associated with each player are also unveiled in this report.
This report is specially curated to empower the existing players, stakeholders, and new entrants about the ongoing trends of this market which will allow them to make informed business-centric decisions.
Browse In-depth Market Research Report (300 Pages) on DNA Diagnostic Market:
DNA Diagnostic Market Companies:
Abbott Laboratories,
Hoffmann-La Roche Ltd.,
Bayer Diagnostic,
Illumina Inc.,
Gen-Probe Inc., 
Cephide Inc.,
Johnson and Johnson,
Thermo Fisher Scientific Inc.,
Novartis AG,
Bio-Rad Laboratories Inc.,
Sysmex Corporation, and
others
Regional Insights:
The regions covered in this Global DNA Diagnostic Market report are North America, Europe, Asia-Pacific, and Rest of the World. Based on country level, the market of Managed security service is subdivided into the U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, Southeast Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc.
Global DNA Diagnostic Market Segmentation:
By Product Type
DNA Diagnostics Reagents
DNA Diagnostics Instruments
DNA Diagnostics Software & Services
By Technology
PCR
Microarray
Mass spectrometry
Sequencing Technology
In-situ Hybridization
By Application
Oncology
Pre-Implantation
Infectious Diseases
Clinical Diagnostic Confirmation
Myogenic Disorder
Prenatal Diagnostics
Other
By End-Use
Point of Care
Self-Testing/OTC
Diagnostic Centers
DNA Sequencing Electrophoresis Market is valued at USD 2.38 Billion in 2018 and expected to reach USD 4.2 Billion by 2025 with the CAGR of 6.2% over the forecast period.
0 notes
priyanshisingh · 9 months
Text
Europe RNA/DNA Extraction Kit Market - Future Growth Prospects for the Global Leaders
The latest market report published by Credence Research, Inc. “Global RNA/DNA Extraction Kit Market: Growth, Future Prospects, and Competitive Analysis, 2016 – 2028. The global RNA/DNA extraction kit market has witnessed rapid growth in recent years and is estimated to grow at a CAGR of 7.9% between 2023 and 2030. The market was valued at USD 1.5 billion in 2022 and is expected to reach USD 2.55 billion in 2030.
Cell-free DNA extraction kits hold the largest market share, followed by sequence-specific RNA kits. These products are extensively used in molecular diagnostics, genetic testing, and research studies. Hospitals and diagnostic centers are the primary end-users of RNA/DNA extraction kits, accounting for a significant portion of the market share.
Despite the challenges of high costs and the need for efficient extraction methods, opportunities for growth abound. Innovative extraction technologies, increasing demand for genetic testing, and investments in genomics research and next-generation sequencing technologies drive this growth.
Geographically, North America leads the global market, followed closely by Europe. However, the Asia-Pacific region, especially China and India, is projected to experience substantial growth due to increased healthcare infrastructure and a focus on precision medicine.
Europe RNA/DNA Extraction Kit Market opportunities are abundant, offering a promising landscape for businesses aiming to tap into the growing demand for advanced genetic research tools. With Europe being at the forefront of scientific innovation, this market presents a multitude of possibilities for companies operating in the field of molecular biology. The ever-expanding applications of RNA and DNA extraction kits in fields such as diagnostics, pharmaceuticals, agriculture, and forensics provide an enticing opportunity for manufacturers and developers alike. Additionally, the increasing prevalence of genetic disorders across Europe has led to a surge in research activities focused on understanding their mechanisms and finding potential remedies. As a result, there is an escalating need for reliable and efficient extraction kits that can cater to these diverse research needs.
Key players in the global RNA/DNA extraction kit market include Qiagen, ThermoFisher Scientific Inc, Roche Holding AG, Agilent Technologies, Bio-Rad Laboratories Inc, Promega Corporation, Danaher Corporation, Merck & Co. Inc, PerkinElmer Inc, and bioMérieux S.A. These companies compete based on product quality, reliability, innovation, pricing, and customer support, and also engage in strategic collaborations, partnerships, mergers, and acquisitions to expand their market presence.
Why to Buy This Report-
The report provides a qualitative as well as quantitative analysis of the global RNA/DNA Extraction Kit Market by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics with the historical period from 2016-2020, the base year- 2021, and the projection period 2022-2028.
The report includes information on the competitive landscape, such as how the market's top competitors operate at the global, regional, and country levels.
Major nations in each region with their import/export statistics
The global RNA/DNA Extraction Kit Market report also includes the analysis of the market at a global, regional, and country-level along with key market trends, major players analysis, market growth strategies, and key application areas.
Browse Full Report: https://www.credenceresearch.com/report/rna-dna-extraction-kit-market
Visit: https://www.credenceresearch.com/
Related Report: https://www.credenceresearch.com/report/membrane-separation-technologies-market
Browse Our Blog: https://www.linkedin.com/pulse/germany-rnadna-extraction-kit-market-size-worth-usd-255-singh
Browse Our Blog: https://tealfeed.com/vietnam-rnadna-extraction-kit-market-rising-rutiz
Browse Our Blog: https://medium.com/@priyanshi_97937/europe-rna-dna-extraction-kit-market-future-growth-prospects-for-the-global-leaders-780d5eedf027
0 notes
ezzybrownmedia · 10 months
Text
Best Male Enhancement pill
Tumblr media
The mission of Nuvialab Vitality, a health and wellness company, is to improve overall health and well-being by offering a variety of products and services. Despite having a wide range of products, the company's line of health supplements stands out. These nutritional supplements are designed to provide the body with the nourishment it needs for maximum functioning.
As the finest Male Enhancement pill, Nuvialab Vitality also offers a range of supplementary health and wellness services, as well as a selection of other goods and services linked to fitness and healthy living. The best male enhancement products increase libido, promote fertility, and intensify sexual desire.
Additionally, it improves physical performance and helps maintain the body's testosterone levels within a healthy range. This supplement provides all-around support for the male physique. The market for food supplements has been deficient in this product. Earn a 30% commission on each transaction while taking advantage of NuviaLab Vitality's great potential!
[The tablet is also GMO-free]. A genetically modified organism (GMO), often referred to as a transgenic organism or a genetically engineered organism, is any animal whose genetic makeup has been changed in a laboratory environment. By doing this, DNA combinations of microbes, plants, and animals are created that are not obtained naturally or by regular crossbreeding. GMOs are created for many various reasons, including increasing agricultural yields, improving the nutritional content and quality of food, and making crops resistant to pests and herbicides.
However, there is much dispute on the safety and regulation of GMOs. The Centre for Food Safety and Applied Nutrition of the FDA oversees GMOs in the US. In the United States, no testing nor labelling of GMOs is required. To be indicated if they contain GMOs, all food products must comply with FDA regulations. GMO usage is outlawed in certain countries, including the European Union. In other countries like China and India, the use and import of GMOs are highly restricted.
[Gluten-free]. All three grains—wheat, rye, and barley—contain the protein called gluten. It facilitates the gas collection that gives bread its chewy texture and rise. Long strands that encapsulate the gas bubbles are created by the combination of water and the gluten proteins found in wheat. This causes gluten-free bread to rise and have a chewy texture.
[Dairy-free]. Dairy goods include milk and anything produced from milk. The mammary glands of animals produce milk, a white liquid. It serves as the primary source of nourishment for young animals until they are able to digest other types of food. Despite the fact that milk's constituents vary based on the species, they typically consist of fat, protein, and lactose. Dairy items include things like yoghurt, ice cream, cheese, and butter.
Dairy products have long been a part of human diets. Dairy products like milk and cheese were among the earliest domesticated staples, and many diverse cultures still rely on them today. Dairy is a great source of minerals including calcium, phosphate, and vitamin A. There are also significant amounts of protein and fat. Dairy products have several positive health effects.
They promote the growth and preservation of strong bones and teeth and are a good source of energy. Dairy products also assist in reducing the risk of a number of chronic conditions, such as type 2 diabetes and heart disease. NuviaLab Vitality is available in tablet and powder form, and both are easy to take.
Learn more...
0 notes
market-insider · 6 months
Text
Forensic Genomics Diagnostics: A Strategic Market Assessment
The global forensic genomics market size is expected to reach USD 1.36 billion by 2030, registering a CAGR of 14.25% in the forecast period, according to a new report by Grand View Research, Inc. This is owing to a significant increase in violent crimes, globally. Murder, intentional homicide, robbery, etc. are the key factors driving the growth of the industry. The Federal Bureau of Investigation predicted that there will be 1.31 million violent crimes in 2021. Homicides accounted for approximately 40.00% since before the pandemic, according to the FBI’s estimated homicide data. Forensic DNA profiling allows the identification of individuals of those who are already known to the investigating authorities.
Forensic Genomics Market Report Highlights
The growth of the overall market is attributed to the increasing crime rates along with the introduction of advanced technology for forensic testing
Key players are focusing on several strategic alliances, which, in turn, is driving the global industry
For instance, in August 2022, Thermo Fisher Scientific entered into collaboration with National Forensic Sciences University (NFSU) to establish the center of excellence for DNA forensics in India
The facility is equipped with advanced technologies, which would help researchers make evidence-based decisions
In August 2022, Verogen, Inc. formed a partnership agreement with Gene by Gene to accelerate Forensic Investigative Genetic Genealogy (FIGG) Adoption
The partnership would provide affordable whole genome sequencing services for complex samples and standardize bioinformatic techniques for FIGG analysis
Gain deeper insights on the market and receive your free copy with TOC now @: Forensic Genomics Market Report
New genetic markers have been produced as a result of recent research and they have the potential to address some significant shortcomings in DNA profiling techniques. In addition, several developments allow new kinds of relevant information to be obtained from biological samples. These include new molecular techniques for locating individuals that investigators were previously unaware of, and novel molecular approaches to support connections between criminal acts and sample donors. Such advancements in genomics, genetics and molecular biology are expected to enhance human forensic casework in the coming years. Advancements in technology have helped scientists create DNA fingerprints with smaller samples of DNA, therefore a suspect can be identified from a small amount of blood sample.
Next-generation Sequencing (NGS) offers results quickly and at a lower cost than other conventional techniques. Accordingly, to improve DNA testing accuracy, the number of regions used in STR analysis increased from 13 to 20 in 2017. In February 2022, researchers from the University of Washington along with the U.S. Department of Homeland Security used DNA testing of ivory shipments confiscated by law enforcement to identify the global criminal groups involved in ivory smuggling out of Africa. The kits & consumables product segment captured the highest revenue share in 2021 due to the high public & private investments in the development of DNA forensics.
The consumables include centrifuge tubes, cotton swabs, and filter baskets among others. The capillary electrophoresis method segment dominated the industry in 2021. Capillary electrophoresis is a fully automated technique used for detecting and separating Short Tandem Repeat (STR) alleles in genomic laboratories. Criminal testing was the largest application segment in 2021 owing to the increasing use of molecular testing technology for criminal investigation. North America dominated the global industry in 2021 due to various technological developments in the forensic sciences and growing investigation consent for forensic processes, such as biometric analysis methods and DNA profiling.
0 notes